Cargando…

Differences in the genomic profiles of cell‐free DNA between plasma, sputum, urine, and tumor tissue in advanced NSCLC

Liquid biopsy has provided an efficient way for detection of gene alterations in advanced non‐small‐cell lung cancer (NSCLC). However, the correlation between systematic determination of somatic genomic alterations in liquid biopsy and tumor biopsy still remained unclear, and the concordance rate be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Zhen, Yang, Zhen, Li, Chun Sun, Zhao, Wei, Liang, Zhi Xin, Dai, Yu, Zhu, Qiang, Miao, Kai Ling, Cui, Dong Hua, Chen, Liang An
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434190/ https://www.ncbi.nlm.nih.gov/pubmed/30767431 http://dx.doi.org/10.1002/cam4.1935

Ejemplares similares

Non-invasive detection of EGFR and TP53 mutations through the combination of plasma, urine and sputum in advanced non-small cell lung cancer
por: Wu, Zhen, et al.
Publicado: (2019)

Sputum cell‐free DNA: Valued surrogate sample for the detection of EGFR exon 20 p.T790M mutation in patients with advanced lung adenocarcinoma and acquired resistance to EGFR‐TKIs
por: Wang, Zheng, et al.
Publicado: (2021)

Plasma and Urine Free Glycosaminoglycans as Monitoring Biomarkers in Nonmetastatic Renal Cell Carcinoma—A Prospective Cohort Study
por: Gatto, Francesco, et al.
Publicado: (2022)

Assessment of somatic mutations in urine and plasma of Wilms tumor patients
por: Miguez, Ana Carolina Kerekes, et al.
Publicado: (2020)

Real‐world outcomes of NSCLC patients receiving tissue or circulating tumor DNA‐guided osimertinib treatment
por: Su, Po‐Lan, et al.
Publicado: (2019)

Notes on the Examination of the Sputum, Vomit, Fæces, and Urine
Publicado: (1891)

Notes on the Examination of the Sputum, Vomit, Fæces, and Urine
Publicado: (1891)

Transforming growth factor-β(1) induces connective tissue growth factor expression and promotes peritoneal metastasis of gastric cancer
por: Lv, Ling, et al.
Publicado: (2020)

The Prediction Of Epidermal Growth Factor Receptor Mutation And Prognosis Of EGFR Tyrosine Kinase Inhibitor By Serum Ferritin In Advanced NSCLC
por: Wu, Zhen, et al.
Publicado: (2019)

Probing of breast cancer using a combination of plasma and urinary circulating cell-free DNA
por: Zuo, Zhigang, et al.
Publicado: (2020)

Comprehensive analysis of long noncoding RNA and mRNA in five colorectal cancer tissues and five normal tissues
por: Zhou, Zhen-Xu, et al.
Publicado: (2020)

Correlation Between RASSF1A Gene Promoter Hypermethylation in Serum or Sputum and Non-Small Cell Lung Cancer (NSCLC): A Meta-Analysis
por: Zhang, Zhen, et al.
Publicado: (2019)

The multicomponent residue depletion of Gelsemium elegans in pig tissues, urine, and plasma
por: Wu, Yong, et al.
Publicado: (2023)

Coupland's Notes on the Examination of Sputum, Vomit, Fœces and Urine
Publicado: (1891)

Dioscorides Phakas on the Detection of Iron in Blood, Urine and Sputum
por: Nierenstein, M.
Publicado: (1946)

Notes on the Examination of the Sputum, Vomit, Fæces, Urine and Blood
Publicado: (1892)

Cellular Therapy in NSCLC: Between Myth and Reality
por: Imbimbo, Martina, et al.
Publicado: (2023)

Efficacy and safety of osimertinib in treating EGFR‐mutated advanced NSCLC: A meta‐analysis
por: Yi, Lilan, et al.
Publicado: (2019)

Delineating the pattern of treatment for elderly locally advanced NSCLC and predicting outcomes by a validated model: A SEER based analysis
por: Guo, Meiying, et al.
Publicado: (2019)

Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer
por: Christensen, Emil, et al.
Publicado: (2023)

Long non-coding RNA RP11-284P20.2 promotes cell proliferation and invasion in hepatocellular carcinoma by recruiting EIF3b to induce c-met protein synthesis
por: Fang, Qin-Liang, et al.
Publicado: (2020)

EGFR mutation analysis on circulating free DNA in NSCLC: a single-center experience
por: Ianza, Anna, et al.
Publicado: (2021)

Development of a preoperative prognostic scoring system to predict benefits of hepatic resection in advanced hepatocellular carcinoma patients
por: Chen, Chang-Zhi, et al.
Publicado: (2021)

Clinical outcomes of EGFR kinase domain duplication to targeted therapies in NSCLC
por: Wang, Jinguang, et al.
Publicado: (2018)

Sorafenib synergizes with metformin in NSCLC through AMPK pathway activation
por: Groenendijk, Floris H, et al.
Publicado: (2015)

Driver genes as predictive indicators of brain metastasis in patients with advanced NSCLC: EGFR, ALK, and RET gene mutations
por: Wang, Huijuan, et al.
Publicado: (2019)

Prognostic effect of body mass index in patients with advanced NSCLC treated with chemoimmunotherapy combinations
por: Cortellini, Alessio, et al.
Publicado: (2022)

Long-term Clinical Outcomes and Safety Profile of SBRT for Centrally Located NSCLC
por: Arnett, Andrea L.H., et al.
Publicado: (2019)

A clinical variable‐based nomogram could predict the survival for advanced NSCLC patients receiving second‐line atezolizumab
por: Shang, Xiaoling, et al.
Publicado: (2021)

Systematic analysis of concentrations of 52 elements in tumor and counterpart normal tissues of patients with non‐small cell lung cancer
por: Cheng, Xin, et al.
Publicado: (2019)

Prognostic value of aberrantly expressed methylation genes in human hepatocellular carcinoma
por: Zhen, Limin, et al.
Publicado: (2020)

SNAI2 and TWIST1 in lymph node progression in early stages of NSCLC patients
por: Emprou, Camille, et al.
Publicado: (2018)

ALK Inhibitors or Chemotherapy for Third Line in ALK-positive NSCLC? Real-world Data
por: Moskovitz, Mor, et al.
Publicado: (2022)

Development and validation of nomogram to predict risk of survival in patients with laryngeal squamous cell carcinoma
por: Cui, Jie, et al.
Publicado: (2020)

Phosphopeptide Enrichment Coupled with Label-free Quantitative Mass Spectrometry to Investigate the Phosphoproteome in Prostate Cancer
por: Cheng, Larry C., et al.
Publicado: (2018)

An electrochemical biosensor for the detection of Mycobacterium tuberculosis DNA from sputum and urine samples
por: Ramos-Sono, Daniel, et al.
Publicado: (2020)

Multimodal analysis of methylomics and fragmentomics in plasma cell-free DNA for multi-cancer early detection and localization
por: Nguyen, Van Thien Chi, et al.
Publicado: (2023)

Combined treatment with N‐acetylcysteine and gefitinib overcomes drug resistance to gefitinib in NSCLC cell line
por: Li, Jun, et al.
Publicado: (2019)

Genome-wide CRISPR screening reveals genetic modifiers of mutant EGFR dependence in human NSCLC
por: Zeng, Hao, et al.
Publicado: (2019)

The predictive value of serum lipids for eye metastases in male nasopharyngeal carcinoma patients
por: Xie, Zhen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pvrv9bpeu7c5is4d5fp5e0s91l